BOSTON--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
Kimberly A. White has been appointed Senior Vice President and Chief
Communications Officer. Ms. White will begin her role with Vertex on May
21, 2018, and will report to Michael J. Parini, Executive Vice
President, Chief Legal and Administrative Officer. In her role, Ms.
White will be responsible for leading the global corporate
communications function, spanning product communications, media
relations, digital and social communications, internal communications,
corporate social responsibility and community affairs. Ms. White most
recently served as Global Chair of the Health Sector at Edelman.
"We are thrilled to welcome Kym to the leadership team and to have her
extensive experience across industry here at Vertex," said Michael
Parini. "Kym has the skill, management capabilities and industry acumen
we need to evolve our communications efforts as Vertex continues to
emerge as a leading global biotechnology company."
"Vertex is on an incredible growth trajectory and is transforming the
lives of patients with serious diseases," said Ms. White. "The
opportunity to tell that story and help advance understanding of the
work of the dedicated scientists and researchers at Vertex compelled me
to join them in this mission."
KIMBERLY WHITE BIOGRAPHY:
Ms. White is a seasoned
communications professional who has provided strategic leadership to
companies in the global healthcare and pharmaceutical industries both
in-house and as an agency advisor. Her expertise includes corporate
reputation, issues and crisis management, brand marketing, media
relations, corporate identity, internal communications and executive
positioning.
She spent the last seven years at Edelman, where she headed the agency's
global healthcare sector and led a team of 600 people worldwide. During
her time at Edelman, Ms. White developed and implemented U.S. and global
communications programs for a wide variety of companies and
organizations in the healthcare industry. Before Edelman, she was the
Chief Communications Officer at Baxter International Inc., where she led
Baxter's global communications function. Ms. White also spent more than
15 years with Ogilvy PR Worldwide, including as the Co-Managing Director
of the agency's global healthcare practice.
Last year, Ms. White was recognized as one of the top 10 health
influencers by PR Week. She also served as a 2017 Cannes Health
Lions Pharma Juror.
About Vertex
Vertex is a global biotechnology company that
invests in scientific innovation to create transformative medicines for
people with serious and life-threatening diseases. In addition to
clinical development programs in CF, Vertex has more than a dozen
ongoing research programs focused on the underlying mechanisms of other
serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now
located in Boston's Innovation District. Today, the company has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. Vertex is consistently recognized as one
of the industry's top places to work, including being named to Science
magazine's Top Employers in the life sciences ranking for eight years in
a row.
For additional information and the latest updates from the company,
please visit www.vrtx.com.
(VRTX-GEN)
View source version on businesswire.com: https://www.businesswire.com/news/home/20180329006063/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael
Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach
Barber, 617-341-6470
or
Media:
Heather Nichols,
617-341-6992
mediainfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
